Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced the resignation of Mr. Wu Changhai from his roles as an executive director, a member of the Nomination and Remuneration Committee, and other positions within its subsidiaries due to work adjustments. His departure does not affect the statutory minimum number of board members or the board’s operations, and an election for a new director will be conducted following statutory procedures. The company expressed gratitude for Mr. Wu’s contributions during his tenure.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company established in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the development, production, and sale of pharmaceutical products, focusing on both traditional Chinese medicine and modern pharmaceuticals.
YTD Price Performance: -0.87%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.73B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.